Buprenorphine, autism diagnoses, and long Covid: the most-read First Opinion essays of 2023

In a year of abortion restrictions, biotech industry upheaval, and revolutionary drug approvals, First Opinion strived to publish the most surprising, provocative, and conversation-starting essays from a wide variety of contributors. Below, you’ll find our top six most-read articles of the year by page views. Why six instead of five? Because why not? And if…

Read More